With ten approved influenza vaccines, on the U.S. market right now, across three main production methods — eggs, cell cultures, and recombinant protein, do we need a genetic mRNA product?
The annual influenza vaccine campaign led by the CDC has become a major public health failure with minimal efficacy and rising concerns of the shots causing more colds and flu while raising the risks of serious conditions like paralysis from Guillain-Barre Syndrome. This story was outlined by Alter AI.
